Cargando…
An Aggregate Biomarker Risk Score Predicts High Risk of Near‐Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes)
BACKGROUND: In a previous study, we found that a biomarker risk score (BRS) comprised of C‐reactive protein, fibrin‐degradation products, and heat shock protein‐70 predicts risk of myocardial infarction and death in coronary artery disease patients. We sought to: (1) validate the BRS in the independ...
Autores principales: | Ghasemzadeh, Nima, Brooks, Maria M., Vlachos, Helen, Hardison, Regina, Sikora, Sergey, Sperling, Laurence, Quyyumi, Arshed A., Epstein, Stephen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586254/ https://www.ncbi.nlm.nih.gov/pubmed/28673897 http://dx.doi.org/10.1161/JAHA.116.003587 |
Ejemplares similares
-
Association Between Increased Platelet P-Selectin Expression and Obesity in Patients With Type 2 Diabetes: A BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy
por: Schneider, David J., et al.
Publicado: (2009) -
The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
por: Singh, Premranjan P., et al.
Publicado: (2011) -
Risk Factors for Incident Peripheral Arterial Disease in Type 2 Diabetes: Results From the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) Trial
por: Althouse, Andrew D., et al.
Publicado: (2014) -
Impact of Glycemic Control Strategies on the Progression of Diabetic Peripheral Neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort
por: Pop-Busui, Rodica, et al.
Publicado: (2013) -
Favorable Effects of Insulin Sensitizers Pertinent to Peripheral Arterial Disease in Type 2 Diabetes: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
por: Althouse, Andrew D., et al.
Publicado: (2013)